Novo Nordisk's pricing approaches while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, mentioning the stark distinction amongst U.S. price ranges and those in Europe and copyright. Novo Nordisk is associated with